TTNP — Titan Pharmaceuticals Share News
0.000.00%
Titan Pharma rises as co starts strategic alternatives review
Brief: Titan Pharmaceuticals To Explore Strategic Alternatives
U.S. STOCKS ON THE MOVE-Remark Holdings, Erytech Pharma, Pinterest, Bakkt Holdings
U.S. STOCKS ON THE MOVE-Pinterest, Tesla, Erytech Pharma, Remark
U.S. STOCKS ON THE MOVE-Remark Holdings, PAE, Tesla, Xeris
Titan Pharma jumps on funding from Bill & Melinda Gates Foundation
Brief: Titan Pharmaceuticals Receives Funding To Develop Combination HIV Therapeutic And Contraceptive Implant
Brief: Titan Pharmaceuticals Inc And Musc Frd Enter Into Research And Option License Agreement
Titan Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
U.S. STOCKS ON THE MOVE-Tesla, Occidental Petroleum, Torchlight Energy
U.S. STOCKS ON THE MOVE-Tesla, Occidental Petroleum, Diamondback Energy, Biogen
Titan Pharma up after itching therapy implant shows promise in animal study
Brief: Titan Announces Positive Results From The First Studies Of TP-2021 Implant
Titan Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Brief: Positive Early Study Results Help Pave Wave For Titan Pharmaceuticals To Move Forward With Its JT-09 ProNeura Development Program
Brief: Titan Pharmaceuticals Inc Files For Resale Of Up To 2.73 Million Shares Of Common Stock By The Selling Stockholders - SEC Filing
Brief: Titan Pharmaceuticals Announces Pricing Of $9.7 Mln Registered Direct Offering
Brief: Titan Pharmaceuticals Says Nasdaq Notified That Co No Longer In Compliance With Listing Rules
Brief: Titan Pharmaceuticals Says Was Unable To Convene Stockholders Annual Meeting As It Could Not Form A Quorum